Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Equity Average: 2022-2024

Historic Equity Average for LifeStance Health (LFST) over the last 3 years, with FY2024 value amounting to $1.4 billion.

  • LifeStance Health's Equity Average rose 347.18% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 347.18%. This contributed to the annual value of $1.4 billion for FY2024, which is 245.75% down from last year.
  • LifeStance Health's Equity Average amounted to $1.4 billion in FY2024, which was down 245.75% from $1.5 billion recorded in FY2023.
  • In the past 5 years, LifeStance Health's Equity Average registered a high of $1.5 billion during FY2022, and its lowest value of $1.4 billion during FY2024.
  • Over the past 3 years, LifeStance Health's median Equity Average value was $1.5 billion (recorded in 2023), while the average stood at $1.5 billion.
  • Its Equity Average has fluctuated over the past 5 years, first crashed by 378.94% in 2023, then tumbled by 245.75% in 2024.
  • Annual analysis of 3 years shows LifeStance Health's Equity Average stood at $1.5 billion in 2022, then fell by 3.79% to $1.5 billion in 2023, then decreased by 2.46% to $1.4 billion in 2024.
  • Its last three reported values are $1.4 billion in FY2024, $1.5 billion for FY2023, and $1.5 billion during FY2022.